Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
---|
02/20/2002 | CN1336437A Two-saccharomycetes strains and its usage in preparing optically pure 2-aryl propionic acid |
02/20/2002 | CN1336436A Method of improving soluble expression of foreign gene in colon bacillus |
02/20/2002 | CN1336433A Prepn. and application of properly cooled proteinase with special flavor |
02/20/2002 | CN1336432A Production process and biological activity of recombinant exarid kinase |
02/20/2002 | CN1336381A Trichosanthin mutant and its prepn. |
02/20/2002 | CN1336370A 3-deoxy-3-carbonyl-erycin lactone B and its engineeirng strain and application |
02/20/2002 | CN1336099A Fast strain prepn. for edible and medicinal fungus |
02/20/2002 | CN1079435C Method for preparing human red blood cell culture medium |
02/20/2002 | CN1079204C Chinese caterpillar fungus feeds additive and its prodn. method |
02/19/2002 | US6348639 Biological system for degrading nitroaromatics in water and soils |
02/19/2002 | US6348584 Fibronectin binding protein compounds |
02/19/2002 | US6348582 Prokaryotic polynucleotides polypeptides and their uses |
02/19/2002 | US6348578 Apt |
02/19/2002 | US6348574 An antibody; diagnosis and therapy for tumors, strokes, vasoconstriction, bronchial asthma, and atherosclerosis |
02/19/2002 | US6348569 Spruce budworm antifreeze proteins, genes and method of using same |
02/19/2002 | US6348353 Artificial mammalian chromosome |
02/19/2002 | US6348351 Tie receptor tyrosine kinase ligand homologues |
02/19/2002 | US6348346 Inhibition culture agglutination in fermentation |
02/19/2002 | US6348344 Genetically modified cells and methods for expressing recombinant heparanase and methods of purifying same |
02/19/2002 | US6348335 Metabolism active materials, heating and cooling yeasts then isolation |
02/19/2002 | US6348331 Pichia methanolica glyceraldehyde-3-phosphate dehydrogenase 2 promoter |
02/19/2002 | US6348329 Isolation of polynucleotide sequence codes of polypeptide with amino acid sequences |
02/19/2002 | US6348314 Invasive cleavage of nucleic acids |
02/19/2002 | US6348201 Sphingoglycolipid available as cosmetic and medicine, has potent moisturizing effeact and preventive effect against skin roughness; sphinogglycolipid containing sugar moities and amide group |
02/19/2002 | CA2141060C Cyclic gmp-binding, cyclic gmp-specific phosphodiesterase materials and methods |
02/19/2002 | CA2032963C Process for producing 7-aminocephem compound or salts thereof |
02/19/2002 | CA2023246C Mutants of human interleukin-3 |
02/18/2002 | CA2354653A1 Peptide mutant of human erab/hadh2, its x-ray crystal structure, and materials and method for identification of inhibitors thereof |
02/14/2002 | WO2002012901A2 Use of grf1 protein for screening molecules |
02/14/2002 | WO2002012537A2 Mutant trichosanthin |
02/14/2002 | WO2002012536A1 Modified yeasts and uses thereof, in particular for producing steroid derivatives |
02/14/2002 | WO2002012530A2 3-hydroxycarboxylic acid production and use in branched polymers |
02/14/2002 | WO2002012528A2 Enhanced 2-keto-l-gulonic acid production |
02/14/2002 | WO2002012519A2 Counter selection strategy for gram-negative bacteria |
02/14/2002 | WO2002012515A1 Assays for alternative lengthening of telomeres |
02/14/2002 | WO2002012506A1 Lactobacillus rhamnosus polynucleotides, polypeptides and methods for using them |
02/14/2002 | WO2002012505A1 Nucleotide sequences which code for the lysr3 gene |
02/14/2002 | WO2002012504A1 Nucleotide sequences which code for the lysr2 gene |
02/14/2002 | WO2002012500A2 Anti-il-12 antibodies, compositions, methods and uses |
02/14/2002 | WO2002012495A1 Protein induced by homogeneous blood transfusion and dna encoding the same |
02/14/2002 | WO2002012485A1 Promoter, vector and recombinant microorganism having the same and process for producing protein |
02/14/2002 | WO2002012482A1 Scavenger receptor and use thereof |
02/14/2002 | WO2002012481A2 Enhancement of industrial production by increasing substrate transport |
02/14/2002 | WO2002012475A2 C1q-related factor, homologous polypeptides and therapeutic uses thereof |
02/14/2002 | WO2002012470A2 A member of the lysyl oxidase gene family |
02/14/2002 | WO2002012468A2 2,5-dkg permeases |
02/14/2002 | WO2002012467A2 Drug metabolizing enzymes |
02/14/2002 | WO2002012466A2 Mutant trichoderma reesei egiii cellulases, dna encoding such egiii compositions and methods for obtaining same |
02/14/2002 | WO2002012465A2 Mutant trichoderma reesei egiii cellulases, dna encoding such egiii compositions and methods for obtaining same |
02/14/2002 | WO2002012464A2 Mutant trichoderma reesei egiii cellulases dna encoding such egiii compositions and methods for obtaining same |
02/14/2002 | WO2002012463A2 Mutant trichoderma reesei egiii cellulases, dna encoding such egiii compositions and methods for obtaining same |
02/14/2002 | WO2002012462A2 Mutant trichoderma reesei egiii cellulases, dna encoding such egiii compositions and methods for obtaining same |
02/14/2002 | WO2002012461A2 Regulation of human membrane-type serine protease |
02/14/2002 | WO2002012456A2 Ampk-related serine/threonine kinase, designated snark |
02/14/2002 | WO2002012446A1 Transformation and modification of natural drug by intestinal probiotic fermentative culture |
02/14/2002 | WO2002012345A2 Soluble zcytor 11 cytokine receptors |
02/14/2002 | WO2002012340A2 Transporters and ion channels |
02/14/2002 | WO2002012339A2 Sequences for integrin alpha-8 |
02/14/2002 | WO2002012326A2 Mechanism of conditional regulation of the hypoxia-inducible factor-1 by the von hippel-lindau tumor suppressor protein |
02/14/2002 | WO2002012325A2 Suppressor gene |
02/14/2002 | WO2002012307A1 Urocortin proteins and uses thereof |
02/14/2002 | WO2002012295A1 New nucleotide sequences coding for the lysr1 gene |
02/14/2002 | WO2002012294A2 Group b streptococcus polypeptides nucleic acids and therapeutic compositions and vaccines thereof |
02/14/2002 | WO2002012291A2 Novel nucleotide sequences coding for the luxr gene and a process for the production of l-amino acids |
02/14/2002 | WO2002012290A2 Sid polypeptides binding to pathogenic strain of the hepatitis c virus |
02/14/2002 | WO2002012288A2 Vaccination against host cell-associated herpesviruses |
02/14/2002 | WO2002012286A2 Stress proteins and peptides and methods of use thereof |
02/14/2002 | WO2002012279A2 Schizophrenia related gene and protein |
02/14/2002 | WO2002012274A2 Iapl-3 a protein inhibitor of apoptosis proteins |
02/14/2002 | WO2002012268A1 Motor proteins and methods for their use |
02/14/2002 | WO2002012183A1 Process for extracting astaxanthin pigment from blue-green algae and extracted pigment thereof |
02/14/2002 | WO2002012136A1 Waste water treatment method using microorganisms |
02/14/2002 | WO2002011769A1 Vascular endothelial growth factor 2 |
02/14/2002 | WO2002011746A2 Chlorella preparations exhibiting immunomodulating properties |
02/14/2002 | WO2002011563A1 Food supplement |
02/14/2002 | WO2001098471A8 Human phosphodiesterases |
02/14/2002 | WO2001081415A9 Parathyroid hormone and parathyroid hormone-related protein antagonists |
02/14/2002 | WO2001073082A3 Methods and cells for expression of recombinant protein products |
02/14/2002 | WO2001073080A3 Recombinant iron uptake proteins |
02/14/2002 | WO2001073018A3 Human tap-like protein (transporter associated in antigen processing/presentation) |
02/14/2002 | WO2001072838A3 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
02/14/2002 | WO2001068796A3 Method of aerating yeast prior to pitching |
02/14/2002 | WO2001064874A3 Low density liprotein binding proteins and their use in diagnosing and treating atherosclerosis |
02/14/2002 | WO2001062954A8 Stearoyl-coa desaturase to identify triglyceride reducing therapeutic agents |
02/14/2002 | WO2001059120A3 Il-17 like molecules and uses thereof |
02/14/2002 | WO2001058951A3 Water-soluble ligand-binding proteins of ligand-gated ion channels, crystals thereof and their use for screening ligands of ligand-gated ion channels |
02/14/2002 | WO2001058921A3 Methods and compositions for generating angiostatin |
02/14/2002 | WO2001058915A3 Human g-protein chemokine receptor (ccr5) hdgnr10 |
02/14/2002 | WO2001057210A3 Use of dendroaspin as a vehicle for non-dendroaspin domains |
02/14/2002 | WO2001055302A3 Nucleic acids, proteins, and antibodies |
02/14/2002 | WO2001050852A3 Cryopreservation vial apparatus and methods |
02/14/2002 | WO2001049833A3 Recombinant pinoresinol/lariciresinol reductase, recombinant dirigent protein, and methods of use |
02/14/2002 | WO2001048161A3 Human heparanase-related polypeptide and nucleic acid |
02/14/2002 | WO2001047473A3 Magnesium enriched extract of blue-green alga spirulina and the use thereof in cosmetic and dermatological skin-care and body care agents |
02/14/2002 | WO2001044489A3 Galactomannan oligosaccharides and methods for the production and use thereof |
02/14/2002 | WO2001042288A3 G-protein coupled receptors |
02/14/2002 | WO2001034641A3 Antimicrobial activity of the first cationic cluster of human lactoferrin |
02/14/2002 | WO2001021771A3 Compositions and methods for inhibiting g2 cell cycle arrest and sensitizing cells to dna damaging agents |
02/14/2002 | WO2000068258A3 Compounds exhibiting an antibiotic activity |
02/14/2002 | WO2000044908A9 Comp/tsp-1, comp/tsp-2 and other tsp chimeric proteins |